• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

角化棘皮瘤和角化棘皮瘤样鳞状细胞癌:形态相似但发病机制不同。

Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.

作者信息

Watanabe Isabela C, Magalhães Renata F, de Moraes Aparecida M, Stelini Rafael F, Cintra Geórgia F, Metze Konradin, Cintra Maria L

机构信息

From the Department of Pathology (ICW, RFS, GFC, KM, MLC); Department of Dermatology (RFM, AMM), Medical Sciences School, State University of Campinas, Campinas, Brazil.

出版信息

Medicine (Baltimore). 2015 Jun;94(23):e934. doi: 10.1097/MD.0000000000000934.

DOI:10.1097/MD.0000000000000934
PMID:26061320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4616484/
Abstract

Differential diagnosis between keratoacanthoma (KA) and squamous cell carcinoma (SCC) is difficult due to their similarities. The mechanisms that drive their distinct biological behavior are poorly understood. To investigate whether the assessment of microvessel density (MVD) could be helpful in KA and SCC differential diagnosis and to gain insight into the pathogenesis of KA-like neoplasms, we compared the density of CD105- and CD34-stained vessels in KAs and SCCs and their relation to the expression of the p53 oncoprotein and proliferation marker Ki67. This is an observational retrospective cohort study. Forty lesions with clinical appearance of KAs (29 KAs and 11 SCCs) entered the study. A biopsy was taken from each lesion at presentation and the natural clinical course was monitored for at least 1 month. Growing or minimally regressing lesions were submitted to complete surgical excision. The diagnoses were established on combined clinical, histological, and follow-up evaluations. The MVD and p53 or Ki67 expression in neoplastic cells were assessed through morphometry. The MVD did not show discriminating power between KAs and SCCs. The Ki67 proliferation rate was significantly higher in SCCs. Although neoangiogenesis (CD105-MVD) in KAs was associated with cell proliferation, in SCCs it was not. There was significant correlation between p53 expression and neoplasia size in SCCs but not in KAs. From our results, we may conclude that KA and SCC have similarities, as CD105- and CD34-MVD. However, the low Ki67 proliferation index and the positive correlation between Ki-67 index and neovascularization in KA suggest a dependence in neovascularization to grow in KA, pointing to involvement of distinct pathogenesis.

摘要

由于角化棘皮瘤(KA)和鳞状细胞癌(SCC)存在相似性,二者的鉴别诊断较为困难。目前对驱动它们不同生物学行为的机制了解甚少。为了研究微血管密度(MVD)评估是否有助于KA和SCC的鉴别诊断,并深入了解KA样肿瘤的发病机制,我们比较了KA和SCC中CD105和CD34染色血管的密度,以及它们与p53癌蛋白表达和增殖标志物Ki67的关系。这是一项观察性回顾性队列研究。40个临床表现为KA的病变(29个KA和11个SCC)纳入研究。每个病变在就诊时进行活检,并对其自然临床病程进行至少1个月的监测。对生长或仅有轻微消退的病变进行完整手术切除。通过综合临床、组织学和随访评估来确立诊断。通过形态计量学评估肿瘤细胞中的MVD以及p53或Ki67表达。MVD在KA和SCC之间未显示出鉴别能力。SCC中的Ki67增殖率显著更高。尽管KA中的新生血管形成(CD105-MVD)与细胞增殖相关,但在SCC中并非如此。SCC中p53表达与肿瘤大小之间存在显著相关性,而在KA中则没有。从我们的结果可以得出结论,KA和SCC在CD105和CD34-MVD方面存在相似性。然而,KA中较低的Ki67增殖指数以及Ki-67指数与新生血管形成之间的正相关性表明,KA的生长依赖于新生血管形成,这表明其发病机制不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efa/4616484/5e0508084939/medi-94-e934-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efa/4616484/3945b4f2a50a/medi-94-e934-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efa/4616484/707a10f0b44b/medi-94-e934-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efa/4616484/409c4bc21fc1/medi-94-e934-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efa/4616484/bac1519fd60f/medi-94-e934-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efa/4616484/5e0508084939/medi-94-e934-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efa/4616484/3945b4f2a50a/medi-94-e934-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efa/4616484/707a10f0b44b/medi-94-e934-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efa/4616484/409c4bc21fc1/medi-94-e934-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efa/4616484/bac1519fd60f/medi-94-e934-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efa/4616484/5e0508084939/medi-94-e934-g005.jpg

相似文献

1
Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.角化棘皮瘤和角化棘皮瘤样鳞状细胞癌:形态相似但发病机制不同。
Medicine (Baltimore). 2015 Jun;94(23):e934. doi: 10.1097/MD.0000000000000934.
2
Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.免疫功能正常患者的角化棘皮瘤和鳞状细胞癌中Glut-1表达及原位CD1a/CD57免疫缺陷
Appl Immunohistochem Mol Morphol. 2011 May;19(3):239-45. doi: 10.1097/PAI.0b013e3181f7b2f0.
3
Diagnosis and follow-up of keratoacanthoma-like lesions: clinical-histologic study of 43 cases.
J Cutan Med Surg. 2008 Jul-Aug;12(4):163-73. doi: 10.2310/7750.2008.07042.
4
Keratoacanthoma: Update on the Debate.角化棘皮瘤:争议更新。
Am J Dermatopathol. 2021 Apr 1;43(4):305-307. doi: 10.1097/DAD.0000000000001872.
5
Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.具有鳞状表型的角质形成细胞肿瘤(光化性角化病、角化棘皮瘤和皮肤鳞状细胞癌)中桥粒芯糖蛋白1和2的免疫组织化学染色
Br J Cancer. 1998 Apr;77(8):1275-9. doi: 10.1038/bjc.1998.213.
6
Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma.体积加权平均核体积的估计可区分角化棘皮瘤和鳞状细胞癌。
Am J Dermatopathol. 1998 Oct;20(5):453-8. doi: 10.1097/00000372-199810000-00004.
7
Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.细胞周期和凋亡调节蛋白在角化棘皮瘤和鳞状细胞癌中的表达
Pathol Res Pract. 2006;202(8):599-607. doi: 10.1016/j.prp.2006.04.004. Epub 2006 Jun 15.
8
[The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].[层粘连蛋白-322染色在鉴别角化棘皮瘤、伴有鳞状细胞癌区域的角化棘皮瘤和火山口状鳞状细胞癌中的价值]
Actas Dermosifiliogr. 2012 May;103(4):308-16. doi: 10.1016/j.ad.2011.09.004. Epub 2011 Dec 15.
9
The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.异常E-钙黏蛋白及α、β和γ连环蛋白免疫反应性在角化棘皮瘤生物学行为判定中的潜在作用
Br J Dermatol. 2001 Oct;145(4):582-9. doi: 10.1046/j.1365-2133.2001.04459.x.
10
CD30+ cells in regressing keratoacanthoma and in non-keratoacanthomatous squamous cell carcinoma.
Bratisl Lek Listy. 2008;109(11):508-12.

引用本文的文献

1
Squamous Cell Carcinoma: A Clinical and Histopathological Review of a South African Tertiary Dermatology Unit.鳞状细胞癌:南非一家三级皮肤科单位的临床与组织病理学综述
J Skin Cancer. 2025 Jun 20;2025:8884436. doi: 10.1155/jskc/8884436. eCollection 2025.
2
Identifying SCC Lesions Capable of Spontaneous Regression by Using Immunohistochemistry: A Systematic Review and Meta-Analysis.利用免疫组织化学鉴定能够自发消退的鳞状细胞癌病变:一项系统评价和荟萃分析
Dermatol Pract Concept. 2024 Apr 1;14(2):e2024047. doi: 10.5826/dpc.1402a47.
3
Multiple Keratoacanthoma-like Syndromes: Case Report and Literature Review.

本文引用的文献

1
Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.基质CD10表达以及真皮巨噬细胞增多和朗格汉斯细胞减少与角质形成细胞的恶性转化有关。
J Cutan Pathol. 2009 Jun;36(6):668-74. doi: 10.1111/j.1600-0560.2008.01139.x.
2
Diagnosis and follow-up of keratoacanthoma-like lesions: clinical-histologic study of 43 cases.
J Cutan Med Surg. 2008 Jul-Aug;12(4):163-73. doi: 10.2310/7750.2008.07042.
3
Angiogenic switch during tumor progression of carcinoma ex-pleomorphic adenoma.癌性多形性腺瘤肿瘤进展过程中的血管生成开关
多种角化棘皮瘤样综合征:病例报告及文献复习。
Medicina (Kaunas). 2024 Feb 22;60(3):371. doi: 10.3390/medicina60030371.
4
An Analysis of Biopsies for Suspected Skin Cancer at a Tertiary Care Dermatology Clinic in the Western Cape Province of South Africa.南非西开普省一家三级护理皮肤科诊所对疑似皮肤癌活检的分析。
J Skin Cancer. 2020 Jan 27;2020:9061532. doi: 10.1155/2020/9061532. eCollection 2020.
5
A giant keratoacanthoma of the cheek.脸颊部巨大角化棘皮瘤
Acta Biomed. 2019 Dec 23;90(4):580-582. doi: 10.23750/abm.v90i4.7409.
6
Patterns of LC3A Autophagy Protein Expression in Keratoacanthomas.角化棘皮瘤中LC3A自噬蛋白的表达模式
Head Neck Pathol. 2020 Mar;14(1):150-155. doi: 10.1007/s12105-019-01033-1. Epub 2019 Apr 11.
7
Cytokeratin 17 and Ki-67: Immunohistochemical markers for the differential diagnosis of keratoacanthoma and squamous cell carcinoma.细胞角蛋白17和Ki-67:用于角化棘皮瘤和鳞状细胞癌鉴别诊断的免疫组化标志物
Oncol Lett. 2017 Apr;13(4):2539-2548. doi: 10.3892/ol.2017.5793. Epub 2017 Mar 1.
Virchows Arch. 2007 Jul;451(1):65-71. doi: 10.1007/s00428-007-0438-z. Epub 2007 Jun 26.
4
p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.皮肤角化棘皮瘤和鳞状细胞癌中p16的表达:一项免疫组织化学研究
Arch Pathol Lab Med. 2006 Jan;130(1):69-73. doi: 10.5858/2006-130-69-PEIKAS.
5
Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis.人类癌症中血管生成的形态学:概念概述、组织预后观点及新生血管生成的意义
Histopathology. 2005 May;46(5):481-9. doi: 10.1111/j.1365-2559.2005.02142.x.
6
Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies.内皮糖蛋白(CD105)作为血管生成标志物在人类恶性肿瘤中的新兴作用及临床潜力。
Curr Cancer Drug Targets. 2003 Dec;3(6):427-32. doi: 10.2174/1568009033481741.
7
Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density.将血管生成作为人类癌症预后标志物的定量分析:对评估血管密度的组织病理学方法的批判性评价。
Eur J Cancer. 2003 May;39(7):881-90. doi: 10.1016/s0959-8049(02)00663-9.
8
Keratoacanthomas frequently show chromosomal aberrations as assessed by comparative genomic hybridization.
J Invest Dermatol. 2002 Dec;119(6):1367-72. doi: 10.1046/j.1523-1747.2002.19613.x.
9
Carcinoma-like vascular density in atypic keratoacanthoma suggests malignant progression.非典型性角化棘皮瘤中类似癌的血管密度提示恶性进展。
Br J Cancer. 2002 Nov 18;87(11):1301-7. doi: 10.1038/sj.bjc.6600622.
10
Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours.关于实体人类肿瘤血管生成定量评估方法和标准的第二次国际共识
Eur J Cancer. 2002 Aug;38(12):1564-79. doi: 10.1016/s0959-8049(02)00094-1.